Jasper Therapeutics, Inc. (JSPR) ownership: Top institutional holder: GOLDMAN SACHS GROUP INC ($3.20M). Insider activity: Net Seller (0 buys, 9 sells). SEC EDGAR first-party data.
| Holder | Shares | Market Value | Reported |
|---|---|---|---|
| GOLDMAN SACHS GROUP INC | 1746492.00 | $3.20M | 2025-12-31 |
| FRANKLIN RESOURCES INC | 534713.00 | $2.97M | 2025-06-30 |
| VANGUARD GROUP INC | 1326512.00 | $2.43M | 2025-12-31 |
| Velan Capital Investment Management LP | 2668395.00 | $2.34M | 2026-03-31 |
| T. Rowe Price Investment Management, Inc. | 964754.00 | $1.77M | 2025-12-31 |
| MILLENNIUM MANAGEMENT LLC | 1617531.00 | $1.42M | 2026-03-31 |
| ACORN CAPITAL ADVISORS, LLC | 1411492.00 | $1.24M | 2026-03-31 |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1352106.00 | $1.18M | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-07-31 | |
| Sell | null | 2026-07-31 | |
| Sell | null | 2026-07-31 | |
| Sell | null | 2026-07-31 | |
| Sell | null | 2026-07-31 | |
| Sell | null | 2026-07-20 | |
| Sell | null | 2026-07-16 | |
| Sell | null | 2026-07-16 |
Back to JSPR overview · JSPR earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.